These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 8117177

  • 1. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 2. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S.
    Metabolism; 2005 May 28; 54(5):677-81. PubMed ID: 15877299
    [Abstract] [Full Text] [Related]

  • 3. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 4. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun 15; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 15; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Jun 15; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Jun 15; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 8. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 9. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H.
    J Cardiovasc Pharmacol; 1996 Apr 22; 27(4):563-70. PubMed ID: 8847874
    [Abstract] [Full Text] [Related]

  • 10. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 22; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 11. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B.
    Clin Ther; 1991 Feb 22; 13(4):500-10. PubMed ID: 1934003
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Feb 22; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 13. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Feb 22; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 14. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 22; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).
    Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J.
    Am J Cardiol; 2005 Feb 15; 95(4):462-8. PubMed ID: 15695129
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 15; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 17. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 15; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 18. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb 15; 27(2):76-81. PubMed ID: 2921098
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic trial of simvastatin versus fenofibrate in primary hypercholesterolemia].
    Turki S, Mekaouer A, Kaabachi A, Ftouhi B, Mebazaa R, Ben Khalifa F.
    Tunis Med; 1994 Nov 15; 72(11):619-24. PubMed ID: 7762089
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.